Christopher Dinsmore - Feb 15, 2022 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Chief Scientific Officer
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Stock symbol
KRON
Transactions as of
Feb 15, 2022
Transactions value $
$0
Form type
4
Date filed
2/17/2022, 04:21 PM
Previous filing
Dec 15, 2021
Next filing
Jul 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Award $0 +43.6K +51.25% $0.00 129K Feb 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Employee Stock Option (Right to Buy) Award $0 +65K $0.00 65K Feb 15, 2022 Common Stock 65K $7.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.